Abstract
Renal imaging has been enhanced by the introduction of ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI). Each of these imaging modalities represents a unique contribution to detection and staging of renal cell carcinoma. MRI offers several advantages, specifically, determination of tumor origin, evaluation of vascular patency, detection of lymph node metastasis, and evaluation of direct tumor extension into adjacent organs.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call